A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
Therapeutic Advances in Childhood Leukemia Consortium
Therapeutic Advances in Childhood Leukemia Consortium
University of Alabama at Birmingham
Masonic Cancer Center, University of Minnesota
University of Alabama at Birmingham
University of Alabama at Birmingham
Massachusetts General Hospital
Massachusetts General Hospital
Johns Hopkins University
University of Alabama at Birmingham
St. Jude Children's Research Hospital